EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Characteristics of Users and New Initiators of Single- and Multiple-Inhaler Triple Therapy for Chronic Obstructive Pulmonary Disease in Germany

Kai-Michael Beeh iD, Kieran J Rothnie iD, Jing Claussen iD, Fränce Hardtstock iD, Rachel K Knapp iD, Thomas Wilke iD, Alexandrosz Czira iD, Chris Compton iD, Afisi S Ismaila iD

International Journal of Chronic Obstructive Pulmonary Disease · 2024

DOI: 10.2147/copd.s431291 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Chronic Obstructive Pulmonary Disease, 2024. Verfasst von Kai-Michael Beeh und 8 weiteren Autor:innen. Beteiligte Einrichtung: Insaf Respiratory Research Institute, Wiesbaden, Germany. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Muscarinic Antagonists, Bronchodilator Agents, Adrenergic beta-2 Receptor Agonists. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary Disease, Chronic ObstructiveMuscarinic AntagonistsBronchodilator AgentsAdrenergic beta-2 Receptor AgonistsNebulizers and VaporizersGlycopyrrolateDrug CombinationsHumansMaleFemaleRetrospective StudiesGermanyAgedAdministration, InhalationMiddle AgedChlorobenzenesQuinuclidinesTreatment OutcomeBenzyl AlcoholsBeclomethasoneFormoterol FumarateDrug Therapy, CombinationTime FactorsAged, 80 and over

Stichwörter der Autor:innen

COPDGermanyMITTSITTpatient characteristicsreal-world treatment

Substanzen

Muscarinic AntagonistsBronchodilator AgentsAdrenergic beta-2 Receptor AgonistsGlycopyrrolateDrug CombinationsGSK573719ChlorobenzenesQuinuclidinesBenzyl AlcoholsBeclomethasone

Autor:innen und Institutionen

  • Insaf Respiratory Research Institute, Wiesbaden, Germany.
  • Value Evidence and Outcomes, R&D Global Medical, GSK, Brentford, UK.
  • Global Medical Affairs, GSK, Munich, Germany.
  • Real World & Advanced Analytics (RWAA), Cytel, Berlin, Germany.
  • IPAM e.V., Institute affiliated with University of Wismar, Wismar, Germany.
  • Global Medical, GSK, London, UK.

ORCID-Profile: Kai-Michael Beeh, Kieran J Rothnie, Jing Claussen, Fränce Hardtstock, Rachel K Knapp, Thomas Wilke, Alexandrosz Czira, Chris Compton, Afisi S Ismaila

Zitieren

APA

Beeh, K. M., Rothnie, K. J., Claussen, J., Hardtstock, F., Knapp, R. K., Wilke, T., Czira, A., Compton, C., & Ismaila, A. S. (2024). Characteristics of Users and New Initiators of Single- and Multiple-Inhaler Triple Therapy for Chronic Obstructive Pulmonary Disease in Germany. International Journal of Chronic Obstructive Pulmonary Disease. https://doi.org/10.2147/copd.s431291

Vancouver

Beeh KM, Rothnie KJ, Claussen J, Hardtstock F, Knapp RK, Wilke T, et al. Characteristics of Users and New Initiators of Single- and Multiple-Inhaler Triple Therapy for Chronic Obstructive Pulmonary Disease in Germany. International Journal of Chronic Obstructive Pulmonary Disease. 2024. doi:10.2147/copd.s431291

BibTeX
@article{Beeh2024,
  author = {Beeh, Kai-Michael and Rothnie, Kieran J and Claussen, Jing and Hardtstock, Fränce and Knapp, Rachel K and Wilke, Thomas and Czira, Alexandrosz and Compton, Chris and Ismaila, Afisi S},
  title = {Characteristics of Users and New Initiators of Single- and Multiple-Inhaler Triple Therapy for Chronic Obstructive Pulmonary Disease in Germany},
  journal = {International Journal of Chronic Obstructive Pulmonary Disease},
  year = {2024},
  doi = {10.2147/copd.s431291}
}
Kostenlos starten →